| ABM | adjusted body mass; alveolar basement membrane; autologous bone marrow |
|---|---|
| amu | atomic mass unit |
| ASP | abnormal spinal posture; acute symmetric polyarthritis; African swine pox; aged substrate plasma; al... |
| BCM | B-cell maturation; birth control medication; blood-clotting mechanism effects; body cell mass; body ... |
| BMI | body mass index |
| immunization, hib | This vaccine is to prevent disease caused by the haemophilus influenzae type b (hib) bacteria. The h. Influenzae (h. Flu) bacteria can cause a range of serious diseases including meningitis with potential brain damage and epiglottitis with airway obstruction poisoning. The hib vaccine is usually given at 2, 4 and 6 months of age. A final booster is given at 12-15 months of age. Hib vaccine rarely causes severe reactions. (12 Dec 1998) |
|---|---|
| immunization, infectious hepatitis | See Immunization, hepatitis a. (12 Dec 1998) |
| immunization, influenza | See Immunization, flu. (12 Dec 1998) |
| immunization, measles | See Immunization, MMR. (12 Dec 1998) |
| immunization, mmr | The standard vaccine given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most u.s. Colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| immunization, mumps | See Immunization, MMR. (12 Dec 1998) |
| immunization, passive | Transfer of immunity from immunised to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (adoptive transfer). (12 Dec 1998) |
| immunization, pneumococcal pneumonia | This vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
| immunization, polio | The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house. (12 Dec 1998) |
| immunization program | Organised services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international. (12 Dec 1998) |
| immunization, rubella | See Immunization, MMR. (12 Dec 1998) |
| immunization schedule | Schedule giving optimum times usually for primary and/or secondary immunization. (12 Dec 1998) |
| immunization, secondary | Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. (12 Dec 1998) |
| immunization, serum hepatitis | See Immunization, hepatitis b. (12 Dec 1998) |
| immunization, varicella zoster | See Immunization, chickenpox. (12 Dec 1998) |